Search

everythinglearnresearchcommunity

for

Search:↓

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Certain drugs that block specific enzymes can help treat prostate diseases.

Antiandrogens may help treat conditions like excessive hair growth, prostate tumors, male baldness, and acne by blocking male hormone effects.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Tamoxifen effectively treats gynecomastia without causing impotence.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Using finasteride with TIP extends time off period for prostate cancer patients.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Early hair loss may indicate prostate issues.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Ganoderma lucidum may help treat enlarged prostate in rats.